Found: 2
Select item for more details and to access through your institution.
RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 11, p. 2361, doi. 10.1002/1878-0261.12550
- By:
- Publication type:
- Article
Early <sup>18</sup>F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155178
- By:
- Publication type:
- Article